Challenges in the evaluation and reimbursement of high-cost drugs for large patient populations: the controversy around the new drugs for hepatitis C

Faria, R. (Speaker)

Centre for Health Economics

Activity: Talk or presentation › Oral presentation

Period	May 2016
Event title	HTAi 2016 Annual Meeting
Event type	Conference
Location	Tokyo, JapanShow on map
Degree of Recognition	International

Related content

Publications
Prevention of progression to cirrhosis in hepatitis C with fibrosis: effectiveness and cost effectiveness of sequential therapy with new direct-acting anti-virals
Research output: Contribution to journal › Article › peer-review